To further assess the prognostic potential of CCND2 in prostate cancer and determine the relative dependency of PSA recurrence and overall survival, we performed multivariate analysis, including Gleason score, PSA levels, age and clinical T stage. This evidence concerns the gene KLK3 and Familial prostate cancer.